Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
Federal Trade Commission
Healthtrust
Mallinckrodt
Cipla
US Department of Justice
McKinsey
Dow

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070205

« Back to Dashboard

NDA 070205 describes HYDRAMINE, which is a drug marketed by Alpharma Us Pharms and is included in two NDAs. Additional details are available on the HYDRAMINE profile page.

The generic ingredient in HYDRAMINE is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.
Summary for 070205
Tradename:HYDRAMINE
Applicant:Alpharma Us Pharms
Ingredient:diphenhydramine hydrochloride
Patents:0
Therapeutic Class:Antiemetics
Antiparkinson Agents
Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength12.5MG/5ML
Approval Date:Jan 28, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
McKesson
AstraZeneca
Cerilliant
Moodys
Healthtrust
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.